Canaccord Genuity Maintains a 'Buy' on WebMD Health (WBMD); Q1 Exceeds Pre-announcement;
Tweet
Share
E-mailGet Alerts WBMD Hot Sheet
Price: $66.48 --0%
Rating Summary:
3 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
3 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Canaccord Genuity maintains a 'Buy' on WebMD Health Corp. (NASDAQ: WBMD), PT increased to $70.
Canaccord analyst says, "WebMD’s Q1 results exceeded consensus and its recent preannouncement on solid traffic growth, a strong online ad market, and improving inventory monetization. We continue to believe WebMD will be a major beneficiary of the shift of health ad dollars online, given its market-leading position, matchless content database, and broad physician user base. We believe WebMD’s aboveaverage growth and potential for margin expansion outweigh the key risks of regulation and competition."
For more ratings news on WebMD Health Corp. click here and for the rating history of WebMD Health Corp. click here.
Shares of WebMD Health Corp. closed at $56.54 yesterday.
Canaccord analyst says, "WebMD’s Q1 results exceeded consensus and its recent preannouncement on solid traffic growth, a strong online ad market, and improving inventory monetization. We continue to believe WebMD will be a major beneficiary of the shift of health ad dollars online, given its market-leading position, matchless content database, and broad physician user base. We believe WebMD’s aboveaverage growth and potential for margin expansion outweigh the key risks of regulation and competition."
For more ratings news on WebMD Health Corp. click here and for the rating history of WebMD Health Corp. click here.
Shares of WebMD Health Corp. closed at $56.54 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Cantor Fitzgerald Reiterates Overweight Rating on Merlin Labs (MRLN)
- McGraw Hill (MH) PT Raised to $15 at UBS
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
